HOYA stock

7741 · TSE · JPY

¥23,385.00Change from previous close: −2.26%Absolute change: −¥540.00

Close · November 16, 2026

Price history

−2.24% over the period

1 year: from ¥23,920.00 (November 17, 2025) to ¥23,385.00 (November 16, 2026), −2.24%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026¥23,385.00
October 30, 2026¥26,210.00
September 30, 2026¥23,580.00
August 31, 2026¥24,600.00
July 31, 2026¥24,675.00
June 30, 2026¥25,950.00
May 29, 2026¥27,080.00
April 30, 2026¥29,100.00
March 31, 2026¥26,550.00
February 27, 2026¥28,265.00
January 30, 2026¥25,870.00
December 30, 2025¥23,685.00
November 28, 2025¥23,450.00
November 17, 2025¥23,920.00

At a glance

  • The company

    Med-tech company providing eyeglasses, contact lenses, medical endoscopes, intraocular lenses, surgical instruments and semiconductor manufacturing products

  • Latest results

    Quarter to September 30, 2026 · EPS ¥211.83 (estimate ¥194.40)

TickerLandia's take on HOYA

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low¥21,575.00
52-wk high¥30,400.00

−23.08% from the 52-week high

Analysts · 18 analysts

Average target¥30,561.11+30.69% vs. price

Buy 15 · Hold 3 · Sell 0 · Buy

TickerLandia Fingerprint: HOYA

Compared with similar companies: very high financial strength and very high profitability.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

HOYA is priced as in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), HOYA's P/E today is 31.4, in line with the median of its last 10 fiscal years (30.7; between 20.6 and 38.8 from 2017 to 2026). HOYA's P/E (trailing 12 months): 28.7, −33% against the median of a group of 11 similar companies (43.1).

P/E compared with its history

Compared with 11 similar companies

HOYA's metrics compared with similar companies
MetricHOYAPosition in the groupBand
P/E (trailing 12 months)28.7Middle
Forward P/E35.0Middle
Operating margin34.4%High
ROE27.7%High
Debt/equity0.04Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: HOYA. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥259.12B

Latest quarter · Q3 2026

Net income

¥70.71B

Latest quarter · Q3 2026

Quarterly net margin

27.3%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
¥7.93T
P/E
28.7
EPS
¥833.33
Volume
903.1K
Daily trading
€208.4M
Dividend yield
1.41%
Last ex-dividend on September 29, 2026

How HOYA is changing

All results
  • Revenue grew 11.6% a year on average over the last 5 years

  • Operating margin rose from 29.0% to 32.4%

  • Profits turn into cash: free cash flow equal to 93% of net income

Returns

HOYA returns with dividends

¥1,000 invested in HOYA 5 years ago, on November 16, 2021, would be worth ¥1,374 today with dividends reinvested: +37.39% in total, +6.56% per year. On price alone it would be ¥1,311 (+31.12%).

PeriodHOYANikkei 225¥1,000 becomes
1 month−8.83%−6.39%¥912
6 months−16.50%−0.42%¥835
Year to date−1.27%+21.48%¥987
1 year−0.94%+21.52%¥991
3 years+47.36%+82.95%¥1,474
5 years+37.39%+105.15%¥1,374
10 years+478.24%+242.35%¥5,782

Over the last 6 months it has done better than 10% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment

The chart in detail

HOYA: technical analysis

HOYA shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 22.1% below its all-time closing high (¥30,030.00, April 15, 2026).

Trend
No clear trend
RSI (14 sessions)
39
Between 30 and 70
vs 200-session average
−10.68%

Support and resistance

Price areas where HOYA has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance¥26,038.00+11.34%5 touches, last on May 25, 2026
  2. Resistance¥25,060.00+7.16%2 touches, last on June 26, 2026
  3. Resistance¥24,241.67+3.66%6 touches, last on July 8, 2026
  4. Last price¥23,385.00
  5. Support¥23,335.00−0.21%3 touches, last on July 29, 2026

Volatility and risk

Over the last year it has moved less than the Nikkei 225.

Beta (1 year) vs Nikkei 225
0.56
Volatility (60 sessions, annualised)
30.1%
Largest fall in the last year
−25.64%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

HOYA: seasonality

Average monthly price change over 37 years

−0.5%Jan+0.1%Feb+1.9%Mar+1.8%Apr+1.6%May−0.5%Jun+2.9%Jul−0.7%Aug−0.4%Sep+4.3%Oct+1.0%Nov+2.3%Dec

Over the last 37 years, the strongest month for HOYA has been October: +4.27% on average, positive in 25 years out of 37. The weakest has been August: −0.69% on average, positive in 19 years out of 37. November, the current month, has been positive in 19 years out of 36 (+1.00% on average).

Show chart data
MonthAverageMedianPositive years
January−0.50%−1.23%16 of 36
February+0.14%0.00%18 of 37
March+1.93%+2.02%20 of 37
April+1.82%0.00%18 of 37
May+1.58%+2.00%20 of 37
June−0.50%0.00%18 of 37
July+2.89%+1.83%25 of 37
August−0.69%+0.36%19 of 37
September−0.38%+0.72%19 of 37
October+4.27%+2.70%25 of 37
November+1.00%+0.94%19 of 36
December+2.35%+2.73%23 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

HOYA and its competitors

Life Care, the first of the two segments, covers eyeglasses and contact lenses, medical endoscopes, intraocular lenses, and laparoscopic surgical instruments, along with endoscope cleaning equipment and implant-related materials for orthopedics, neurosurgery and dentistry. Through its Eyecity chain it also sells contact lenses directly at retail. The Information and Communications segment supplies mask blanks and photomasks for semiconductor chips and flat panel displays, glass disks for hard disk drives, and optical glass and lenses. The group sells across Japan, Asia, the Americas, Europe and other regions.

Headquarters
Shinjuku, Japan
Employees
37,752
Founded
1941
Chief executive
Eiichiro Ikeda
HOYA and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
HOYA7741$49.59B34.4%28.7−16.50%
Resmed CdiRMD$33.37B34.0%21.7+24.25%
Fisher And Paykel Healthcare CorpoFPH$15.77B27.6%55.6+46.57%
Lenskart SolutionsLENSKART$13.36B10.5%161.2+56.57%
AnsellANN$4.42B15.0%21.9+80.23%
MedlineMDLN$51.94B5.4%89.7+1.96%

Same industry or related industries, similar size. Compare HOYA with its competitors · Full profile